EXCLUSIVE — Merck will be making a $70 billion investment in U.S.-based research and manufacturing starting in 2025, the pharmaceutical company announced on Monday.
The company officially kicked off its planned domestic investment by breaking ground on a $3 billion pharmaceutical manufacturing site in Elkton, Virginia on Monday morning. The new site will employ over 500 full-time workers and create about 8,000 construction jobs within Virginia.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.